Clinical trial

Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics

NCT00655616

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-08-01

PhaseNA

Study timeline

Study start (unknown)2007-08-01Date precision: month

Registry last updated2011-03-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

Montelukast PlaceboDRUG

Salmeterol, MontelukastDRUG

Sponsors & collaborators

University of Dundeelead sponsor

Merck Sharp & Dohme LLCcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00655616 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.